Genocea Provides Fourth Quarter 2020 Corporate Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/10/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
- US consumer sentiment near record low as frustration over economy mounts
- 8.0 Mag. Earthquake 14 Km Sw Of Pitaloza Arriba Panama - USGS
- Strong Panama quake shakes nation, but avoids major destruction
- Nio stock jumps after Goldman Sachs upgrade to buy
- Wall Street posts weekly gains with earnings, inflation data on tap
Genocea Biosciences (GNCA) Tops Q4 EPS by 3c
February 11, 2021 7:35 AM ESTGenocea Biosciences (NASDAQ: GNCA) reported Q4 EPS of ($0.18), $0.03 better than the analyst estimate of ($0.21).
We are extremely pleased to make progress across multiple fronts by using ATLAS unique ability to find the most relevant targets of T cell responses, said Chip Clark, Genocea... More



